Market Value4,513,577,000
Total Holdings105
File Date2021-11-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PFE / Pfizer Inc.
CNC / Centene Corporation
XLRN / Acceleron Pharma Inc
KZR / Kezar Life Sciences, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
CLVS / Clovis Oncology Inc
STVN / Stevanato Group S.p.A.
S / SentinelOne, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
IDYA / IDEAYA Biosciences, Inc.
BPMC / Blueprint Medicines Corporation
INSM / Insmed Incorporated
ALT / Altimmune, Inc.
CAH / Cardinal Health, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SCYX / SCYNEXIS, Inc.
BLSA / BCLS Acquisition Corp - Class A
LSAQ / LifeSci Acquisition II Corp
HARP / Harpoon Therapeutics, Inc.
ABBV / AbbVie Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
AVTR / Avantor, Inc.
BHVN / Biohaven Ltd.
IOVA / Iovance Biotherapeutics, Inc.
DNAD / Social Capital Suvretta Holdings Corp IV - Class A
NEO / NeoGenomics, Inc.
NUVB / Nuvation Bio Inc.
PHVS / Pharvaris N.V.
KYG5960S1241 / Medicus Sciences Acquisition Corp.
/ Nautilus Biotechnology Inc
SGHT / Sight Sciences, Inc.
DNAC / Social Capital Suvretta Holdings Corp III
US83444K1135 / SomaLogic Inc
NPCE / NeuroPace, Inc.
FIGS / FIGS, Inc.
CFLT / Confluent, Inc.
SYNH / Syneos Health Inc - Class A
OMIC / Singular Genomics Systems, Inc.
TKNO / Alpha Teknova, Inc.
CMIIU / CM Life Sciences II Inc - Units (1 Ord Share Class A & 1/5 War)
IMAB / I-Mab - Depositary Receipt (Common Stock)
ZETA / Zeta Global Holdings Corp.
31656R102 / Field Trip Health Ltd. (Canada)
TALS / Talaris Therapeutics Inc
ESMT / EngageSmart, Inc.
DNAA / Social Capital Suvretta Holdings Corp I
SANA / Sana Biotechnology, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
LFST / LifeStance Health Group, Inc.
TNGX / Tango Therapeutics, Inc.
HCAQ / HealthCor Catalio Acquisition Corp - Class A
DYNS / Dynamics Special Purpose Corp Class A
/ CareMax Inc
PATH / UiPath Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
KDMN / Kadmon Holdings Inc
WKME / WalkMe Ltd.
CELC / Celcuity Inc.
MNDY / monday.com Ltd.
FLYW / Flywire Corporation
DNAB / Social Capital Suvretta Holdings Corp II
DOCS / Doximity, Inc.
GHRS / GH Research PLC
ATAI / Atai Life Sciences N.V.
ZIOP / Alaunos Therapeutics Inc
TRIL / Trillium Therapeutics Inc
HOWL / Werewolf Therapeutics, Inc.
TIL / Instil Bio, Inc.
STTK / Shattuck Labs, Inc.
SHC / Sotera Health Company
ARNA / Arena Pharmaceuticals Inc
GLUE / Monte Rosa Therapeutics, Inc.
SLGC / Standard BioTools Inc.
ESPR / Esperion Therapeutics, Inc.
OCDX / Ortho Clinical Diagnostics Holdings PLC
HZNP / Horizon Therapeutics Plc
XLRN / Acceleron Pharma Inc Call
SIBN / SI-BONE, Inc.
EPIX / ESSA Pharma Inc.
SGEN / Seagen Inc
ACAD / ACADIA Pharmaceuticals Inc.
DVAX / Dynavax Technologies Corporation
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
MDT / Medtronic plc
MSAC / Medicus Sciences Acquisition Corp - Class A
ISEE / IVERIC bio Inc
HOLX / Hologic, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
ALNY / Alnylam Pharmaceuticals, Inc.
MRTX / Mirati Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
ACIU / AC Immune SA
PANA / Panacea Acquisition Corp II - Class A
HSAQ / Health Sciences Acquisitions Corp 2
BLU / Bellus Health Inc
ALPN / Alpine Immune Sciences, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
VIR / Vir Biotechnology, Inc.
CTLT / Catalent, Inc.
BAX / Baxter International Inc.
ALDX / Aldeyra Therapeutics, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
SPNE / SeaSpine Holdings Corp
CRDF / Cardiff Oncology, Inc.
RNA / Avidity Biosciences, Inc.
BBIO / BridgeBio Pharma, Inc.
PRTA / Prothena Corporation plc
SMFR / Sema4 Holdings Corp - Class A
DNLI / Denali Therapeutics Inc.
MLTX / MoonLake Immunotherapeutics
ONCS / OncoSec Medical Inc
BIIB / Biogen Inc.
RARE / Ultragenyx Pharmaceutical Inc.
CYTT / Cyteir Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
GRPH / Graphite Bio, Inc.
ACET / Adicet Bio, Inc.
KROS / Keros Therapeutics, Inc.
LLY / Eli Lilly and Company
IPSC / Century Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
UTHR / United Therapeutics Corporation
ARVN / Arvinas, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
NTRA / Natera, Inc.
NBIX / Neurocrine Biosciences, Inc.
KYMR / Kymera Therapeutics, Inc.
GRTS / Gritstone bio, Inc.
NTLA / Intellia Therapeutics, Inc.
EXAS / Exact Sciences Corporation
CRBU / Caribou Biosciences, Inc.